Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1986 3
1988 1
1989 3
1990 5
1991 3
1992 1
1993 1
1994 3
1995 7
1996 1
1997 4
1998 2
1999 7
2000 2
2001 4
2002 1
2004 1
2005 3
2006 1
2008 1
2010 3
2011 3
2016 2
2017 1
2018 2
2019 1
2022 1
Text availability
Article attribute
Article type
Publication date

Search Results

64 results
Results by year
Filters applied: . Clear all
Page 1
Selective inhibitors of COX-2.
O'Neill GP, Kennedy BP, Mancini JA, Kargman S, Ouellet M, Yergey J, Falgueyret JP, Cromlish WA, Payette P, Chan CC, et al. O'Neill GP, et al. Agents Actions Suppl. 1995;46:159-68. doi: 10.1007/978-3-0348-7276-8_16. Agents Actions Suppl. 1995. PMID: 7610986 Review.
National Comprehensive Cancer Network investigational drug service consensus recommendations.
Amin S, Polley S, DeFrates S, Finnes HD, Kinsman K, MacDonald E, Dean L, DeWitt L, Harvey C, Johnston S, Leung TV, Moll EA, O'Neill GP, Redic KA, Park SF. Amin S, et al. Among authors: o neill gp. Am J Health Syst Pharm. 2022 Mar 7;79(6):486-491. doi: 10.1093/ajhp/zxab455. Am J Health Syst Pharm. 2022. PMID: 34849539 No abstract available.
Monoacylglycerol Lipase Inhibition in Human and Rodent Systems Supports Clinical Evaluation of Endocannabinoid Modulators.
Clapper JR, Henry CL, Niphakis MJ, Knize AM, Coppola AR, Simon GM, Ngo N, Herbst RA, Herbst DM, Reed AW, Cisar JS, Weber OD, Viader A, Alexander JP, Cunningham ML, Jones TK, Fraser IP, Grice CA, Ezekowitz RAB, O'Neill GP, Blankman JL. Clapper JR, et al. Among authors: o neill gp. J Pharmacol Exp Ther. 2018 Dec;367(3):494-508. doi: 10.1124/jpet.118.252296. Epub 2018 Oct 10. J Pharmacol Exp Ther. 2018. PMID: 30305428
Reply to A. Braillon, M. Boulin et al, and J.-H. Zhong et al.
Brown KT, Do R, Gönen M, Covey AM, Getrajdman GI, Sofocleous CT, Jarnagin WR, D'Angelica MI, Allen PJ, Erinjeri JP, Brody LA, O'Neill GP, Johnson K, Garcia AR, Beattie CM, Zhao B, Solomon SB, Schwartz LH, DeMatteo RP, Abou-Alfa GK. Brown KT, et al. Among authors: o neill gp. J Clin Oncol. 2017 Jan 10;35(2):258-259. doi: 10.1200/JCO.2016.69.7961. Epub 2016 Oct 23. J Clin Oncol. 2017. PMID: 28056199 No abstract available.
Discovery of MK-7246, a selective CRTH2 antagonist for the treatment of respiratory diseases.
Gallant M, Beaulieu C, Berthelette C, Colucci J, Crackower MA, Dalton C, Denis D, Ducharme Y, Friesen RW, Guay D, Gervais FG, Hamel M, Houle R, Krawczyk CM, Kosjek B, Lau S, Leblanc Y, Lee EE, Levesque JF, Mellon C, Molinaro C, Mullet W, O'Neill GP, O'Shea P, Sawyer N, Sillaots S, Simard D, Slipetz D, Stocco R, Sørensen D, Truong VL, Wong E, Wu J, Zaghdane H, Wang Z. Gallant M, et al. Among authors: o neill gp. Bioorg Med Chem Lett. 2011 Jan 1;21(1):288-93. doi: 10.1016/j.bmcl.2010.11.015. Epub 2010 Nov 5. Bioorg Med Chem Lett. 2011. PMID: 21106375
Randomized Trial of Hepatic Artery Embolization for Hepatocellular Carcinoma Using Doxorubicin-Eluting Microspheres Compared With Embolization With Microspheres Alone.
Brown KT, Do RK, Gonen M, Covey AM, Getrajdman GI, Sofocleous CT, Jarnagin WR, D'Angelica MI, Allen PJ, Erinjeri JP, Brody LA, O'Neill GP, Johnson KN, Garcia AR, Beattie C, Zhao B, Solomon SB, Schwartz LH, DeMatteo R, Abou-Alfa GK. Brown KT, et al. Among authors: o neill gp. J Clin Oncol. 2016 Jun 10;34(17):2046-53. doi: 10.1200/JCO.2015.64.0821. Epub 2016 Feb 1. J Clin Oncol. 2016. PMID: 26834067 Free PMC article. Clinical Trial.
64 results